Application 205811
- Type
- ANDA
- Sponsor
- ACTAVIS LABS FL INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE | DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE | TABLET, DELAYED RELEASE;ORAL | 10MG;10MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0591-2132 | Doxylamine succinate and pyridoxine hydrochloride | Doxylamine succinate and pyridoxine hydrochloride | Actavis Pharma, Inc. | ANDA | Current |
| 0591-2132 | Doxylamine succinate and pyridoxine hydrochloride | Doxylamine succinate and pyridoxine hydrochloride | Actavis Pharma, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 45104 | ORIG | 2016-08-23 |
| 45100 | ORIG | 2016-08-23 |